MARCHIONI, MICHELE
 Distribuzione geografica
Continente #
NA - Nord America 776
AS - Asia 520
SA - Sud America 135
EU - Europa 64
AF - Africa 21
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.518
Nazione #
US - Stati Uniti d'America 748
SG - Singapore 190
CN - Cina 163
BR - Brasile 78
HK - Hong Kong 45
IT - Italia 29
AR - Argentina 21
VN - Vietnam 18
BD - Bangladesh 16
IN - India 15
TR - Turchia 13
ID - Indonesia 10
MX - Messico 10
CO - Colombia 9
EC - Ecuador 9
CA - Canada 8
IQ - Iraq 8
SA - Arabia Saudita 8
PK - Pakistan 7
VE - Venezuela 6
PE - Perù 5
PH - Filippine 5
CL - Cile 4
DE - Germania 4
DZ - Algeria 4
ES - Italia 4
FR - Francia 4
GB - Regno Unito 4
TN - Tunisia 4
UA - Ucraina 4
AE - Emirati Arabi Uniti 3
JM - Giamaica 3
RU - Federazione Russa 3
ZA - Sudafrica 3
AZ - Azerbaigian 2
CR - Costa Rica 2
MA - Marocco 2
NL - Olanda 2
NP - Nepal 2
OM - Oman 2
PT - Portogallo 2
TH - Thailandia 2
UZ - Uzbekistan 2
AL - Albania 1
BB - Barbados 1
BE - Belgio 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
FI - Finlandia 1
GA - Gabon 1
GN - Guinea 1
IE - Irlanda 1
IL - Israele 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
MV - Maldive 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PL - Polonia 1
PS - Palestinian Territory 1
PY - Paraguay 1
RS - Serbia 1
SV - El Salvador 1
SX - ???statistics.table.value.countryCode.SX??? 1
UY - Uruguay 1
ZM - Zambia 1
Totale 1.518
Città #
San Jose 583
Ashburn 111
Beijing 82
Singapore 59
Hong Kong 44
Santa Clara 14
Mexico City 8
São Paulo 8
Ho Chi Minh City 7
Rome 6
Hanoi 5
Lima 5
Yalova 5
Guayaquil 4
Medellín 4
New York 4
Quito 4
Riyadh 4
Barquisimeto 3
Frankfurt am Main 3
Jeddah 3
Agadir 2
Algiers 2
Baghdad 2
Baku 2
Bogotá 2
Chittagong 2
Cuiabá 2
Da Nang 2
Davao City 2
Erbil 2
Jakarta 2
Johannesburg 2
Montreal 2
Muscat 2
Nova Iguaçu 2
Orem 2
Pune 2
Quezon City 2
Ribeirão Preto 2
Rosario 2
San Francisco 2
Sorocaba 2
Sousse 2
Tashkent 2
Verona 2
'Ain Deheb 1
Adapazarı 1
Addis Ababa 1
Ahmedabad 1
Al Ain City 1
Alegrete 1
Alto Araguaia 1
Ambāla 1
Amman 1
Andrelândia 1
Ankara 1
Antakya 1
Antipolo City 1
Antofagasta 1
Aparecida de Goiânia 1
Apucarana 1
Atyrau 1
Auxiliadora 1
Bang Lamung 1
Bangkok 1
Baqubah 1
Beau Bassin-Rose Hill 1
Bedworth 1
Beirut 1
Belo Horizonte 1
Berazategui 1
Besagno 1
Betim 1
Bhopal 1
Blumenau 1
Boa Vista 1
Boston 1
Bowie 1
Bragado 1
Brasília 1
Brno 1
Cabo Frio 1
Cachoeiro de Itapemirim 1
Cairo 1
Campina Grande 1
Campinas 1
Campo Bom 1
Canarana 1
Canmore 1
Canoas 1
Cape Town 1
Castelbellino 1
Chicago 1
Chilliwack 1
Chiniot 1
Christchurch 1
Ciudad del Este 1
Conakry 1
Conchalí 1
Totale 1.070
Nome #
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy 32
Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis 23
Abiraterone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: a systematic review of ‘real-life’ studies 22
Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer 17
Cognition and depression effects of androgen receptor axis-targeted drugs in men with prostate cancer: A systematic review 17
Impact of diagnostic ureteroscopy on intravesical recurrence in patients undergoing radical nephroureterectomy for upper tract urothelial cancer: a systematic review and meta-analysis 17
MP08-03 PROGRESSION-FREE SURVIVAL AS SURROGATE ENDPOINT IN HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER STUDIES: RESULTS FROM A MACHINE LEARNING-BASED ANALYSIS OF A LARGE MULTI-INSTITUTIONAL DATABASE 17
Conspicuity and muscle-invasiveness assessment for bladder cancer using VI-RADS: a multi-reader, contrast-free MRI study to determine optimal b-values for diffusion-weighted imaging 16
Could Bladder Multiparametric MRI Be Introduced in Routine Clinical Practice? Role of the New VI-RADS Score: Results From a Prospective Study 16
Survival of metastatic renal cell carcinoma patients continues to improve over time, even in targeted therapy era 16
Efficacy and safety of intravesical fibrin glue instillation for management of patients with refractory hemorrhagic cystitis: 12-months results. A promising therapy for hemorrhagic cystitis 16
Bladder Neck Contracture After Endoscopic Surgery for Benign Prostatic Obstruction: Incidence, Treatment, and Outcomes 16
Current management of radiation cystitis after pelvic radiotherapy: a systematic review 16
PI-RADS in Predicting csPCa: A Comparison Between Academic and Nonacademic Centers 16
Adjuvant Therapies in Nonmetastatic Renal-Cell Carcinoma: A Review of the Literature 16
Active surveillance for small renal masses in elderly patients does not increase overall mortality rates compared to primary intervention: a propensity score weighted analysis 16
Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors 16
Effects of Curcumin and Lactoferrin to Inhibit the Growth and Migration of Prostatic Cancer Cells 16
Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 ("Oligometastatic") and M2 ("Polymetastatic") subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC) 16
Neobladder "Function": Tips and Tricks for Surgery and Postoperative Management 15
Mastering bladder paraganglioma for optimal treatment: a case report of robot-assisted surgery 15
Changes in renal function after nephroureterectomy for upper urinary tract carcinoma: analysis of a large multicenter cohort (Radical Nephroureterectomy Outcomes (RaNeO) Research Consortium) 15
How Can the COVID-19 Pandemic Lead to Positive Changes in Urology Residency? 14
Robotic versus laparoscopic radical nephrectomy: a large multi-institutional analysis (ROSULA Collaborative Group) 14
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicenter study 14
Efficacy of canakinumab in mild or severe COVID-19 pneumonia 14
Upstaging to pT3a in Patients Undergoing Partial or Radical Nephrectomy for cT1 Renal Tumors: A Systematic Review and Meta-analysis of Outcomes and Predictive Factors 14
Synergistic effects of curcumin and lactoferrin to inhibit the prostatic cancer cells growth and migration ability 14
Off-clamp Versus On-clamp Robot-assisted Partial Nephrectomy: A Systematic Review and Quantitative Synthesis by the European Association of Urology Young Academic Urologists Renal Cancer Study Group 14
Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC) 13
Abiraterone acetate for early stage metastatic prostate cancer: Patient selection and special considerations 13
Persistence and adherence to androgen deprivation therapy in men with prostate cancer: an administrative database study 13
Effect of external beam radiotherapy on second primary cancer risk after radical prostatectomy 13
New Anti-Androgen Compounds Compared to Docetaxel in Metastatic Hormone Sensitive Prostate Cancer: Results from a Network Meta-Analysis 13
RIRS in the elderly: Is it feasible and safe? 13
Complementary roles of surgery and systemic treatment in clear cell renal cell carcinoma 12
Leydig cell tumor in a 53-year-old patient with gynecomastia and gynecodynia: A case report and literature review 12
Cholinergic Markers and Cytokines in OSA Patients 12
Screening programs for renal cell carcinoma: a systematic review by the EAU young academic urologists renal cancer working group 12
Efficacy and Safety of the 64Cu(II)Cl2 PET/CT for Urological Malignancies: Phase IIa Clinical Study 12
North American population-based validation of the National Comprehensive Cancer Network Practice Guideline Recommendations for locoregional lymph node and bone imaging in prostate cancer patients 12
Effect of pathological high-risk features on cancer-specific mortality in non-metastatic clear cell renal cell carcinoma: a tool for optimizing patient selection for adjuvant therapy 12
Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette-Guerin Immunotherapy 12
A drug safety evaluation of abiraterone acetate in the treatment of prostate cancer 11
Improved cancer-specific free survival and overall free survival in contemporary metastatic prostate cancer patients: a population-based study 11
The Surgical Experience Influences the Safety and Efficacy of Photovaporization of Prostate with 180-W XPS GreenLight Laser: Comparison Between Novices vs Expert Surgeons Learning Curves 11
Development and Validation of a Lookup Table for the Prediction of Metastatic Prostate Cancer According to Prostatic-specific Antigen Value, Clinical Tumor Stage, and Gleason Grade Groups 11
NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the NOTCH1 and IGHV Mutational Status 11
Enzalutamide in patients with castration-resistant prostate cancer: retrospective, multicenter, real life study 11
The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT2-3 non-metastatic renal cell carcinoma treated with radical nephrectomy 11
Trifecta and pentafecta rates after robotic assisted partial nephrectomy: Comparative study of patients with renal masses <4 and ≥4 cm 11
Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review 11
High Neutrophil-to-lymphocyte Ratio as Prognostic Factor in Patients Affected by Upper Tract Urothelial Cancer: A Systematic Review and Meta-analysis 11
Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium 11
Radical penectomy, a compromise for life: results from the PECAD study 11
Corrigendum: “Nomogram Predicting Bladder Cancer–specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium” (European Urology Focus (2021) 7(6) (1347–1354), (S240545692030208X), (10.1016/j.euf.2020.07.002)) 11
Transurethral prostate surgery in prostate cancer patients: A population-based comparative analysis of complication and mortality rates 11
Surgical and oncological management of renal medullary carcinoma in a young patient: a case report 11
Management of Urinary Incontinence Following Radical Prostatectomy: Challenges and Solutions 11
Survival after radical prostatectomy or radiotherapy for locally advanced (cT3) prostate cancer 11
Retroperitoneal extension of massive ulcerated testicular seminoma through the inguinal canal: A case report 11
Inferior vena cava involvement in renal cell carcinoma: if you fail to plan, you’re planning to fail 10
Radical prostatectomy or radiotherapy reduce prostate cancer mortality in elderly patients: a population-based propensity score adjusted analysis 10
Potential benefit of lymph node dissection during radical nephrectomy for kidney cancer: A review and critical analysis of current literature 10
Comprehensive analysis of in-hospital delirium after major surgical oncology procedures 10
Nutrigenetic variants and response to diet/lifestyle intervention in obese subjects: a pilot study 10
Radiomics in prostate cancer: an up-to-date review 10
A contemporary analysis of radiotherapy effect in surgically treated retroperitoneal sarcoma 10
Gene Expression Profiling in Coeliac Disease Confirmed the Key Role of the Immune System and Revealed a Molecular Overlap with Non-Celiac Gluten Sensitivity 10
Advanced Age Impacts Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma 10
Racial disparities in lymph node dissection at radical prostatectomy: A Surveillance, Epidemiology and End Results database analysis 10
Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancer 10
Comparison of Perioperative Outcomes between Open and Robotic Radical Cystectomy: A Population-Based Analysis 10
Therapeutic strategies for organ-confined and non-organ-confined bladder cancer after radical cystectomy 10
Postoperative paralytic ileus after major oncological procedures in the enhanced recovery after surgery era: A population based analysis 10
The Clinical Use of the Neutrophil to Lymphocyte Ratio (NLR) in Urothelial Cancer: A Systematic Review 10
Estimating Postoperative Renal Function After Surgery for Nonmetastatic Renal Masses: A Systematic Review of Available Prediction Models 10
Lower Bladder Toxicity of Salvage Versus Adjuvant Modern Radiotherapy for Prostate Cancer Patients 10
The Impact of SARS-CoV-2 Pandemic on Time to Primary, Secondary Resection and Adjuvant Intravesical Therapy in Patients with High-Risk Non-Muscle Invasive Bladder Cancer: A Retrospective Multi-Institutional Cohort Analysis 10
Speed rate (SR) as a new dynamic index of melanoma behavior 9
Comparison of Perioperative Outcomes Between Cytoreductive Radical Prostatectomy and Radical Prostatectomy for Nonmetastatic Prostate Cancer 9
A Head-to-head Comparison of Four Prognostic Models for Prediction of Lymph Node Invasion in African American and Caucasian Individuals 9
Impact of Perioperative Blood Transfusions on the Outcomes of Patients Undergoing Kidney Cancer Surgery: A Systematic Review and Pooled Analysis 9
nAChRs gene expression and neuroinflammation in APPswe/PS1dE9 transgenic mouse 9
The World Health Organization 2022 Classification of renal tumors: key updates for urologists 9
Molecular Imaging Diagnosis of Renal Cancer Using 99mTc-Sestamibi SPECT/CT and Girentuximab PET-CT-Current Evidence and Future Development of Novel Techniques 9
Neoadjuvant chemotherapy before radical cystectomy: Why we must adhere? 9
Detection Rate of Prostate-Specific Membrane Antigen Tracers for Positron Emission Tomography/Computerized Tomography in Prostate Cancer Biochemical Recurrence: A Systematic Review and Network Meta-Analysis 9
Partial nephrectomy seems to confer a survival benefit relative to radical nephrectomy in metastatic renal cell carcinoma 9
PSMA PET/CT in Renal Cell Carcinoma: An Overview of Current Literature 9
Correlation between Choriocapillaris Density and Retinal Sensitivity in Stargardt Disease 9
The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American Patients 9
Publisher Correction: nAChRs gene expression and neuroinflammation in APPswe/PS1dE9 transgenic mouse 9
Development and internal validation of novel nomograms based on benign prostatic obstruction-related parameters to predict the risk of prostate cancer at first prostate biopsy 9
Tumor characteristics, treatments, and oncological outcomes of prostate cancer in men aged ≤50 years: A population-based study 9
Treatment Intensification for Locally Advanced Rectal Cancer: Impact on Pathological Complete Response and Outcomes 9
Optimizing postoperative follow-up in RCC patients: why does it always have to be black and white? 9
Effect of African-American race on cancer specific mortality differs according to clear cell vs. non-clear cell histologic subtype in metastatic renal cell carcinoma 9
Survival benefit of local versus no local treatment for metastatic prostate cancer—Impact of baseline PSA and metastatic substages 9
Management of erectile dysfunction following robot-assisted radical prostatectomy: a systematic review 9
Totale 1.221
Categoria #
all - tutte 4.599
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.599


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202510 0 0 0 0 3 1 1 2 0 0 2 1
2025/20261.682 2 0 4 98 56 17 242 181 846 196 40 0
Totale 1.692